FindOwnerSearch
Brands and Their Owners
| International Stem Cell Corporation contact information is shown below | |
| Owner: | INTERNATIONAL STEM CELL CORPORATION |
|---|---|
| Owner Address: | 9745 Businesspark Ave. San Diego CA 92131 |
| Owner Web Site | |
| Owner Phone | |
| Owner Toll Free | |
| Owner Fax |
| Brand: |
CYTOCOR |
|---|---|
| Description: | Biological tissue, namely, stem cells and tissues derived therefrom for use in treating ophthamlogical diseases, disorders and injuries;Biological tissue, namely, stem cells for scientific research use in the field of ophthamology, and reagents for research and manufacturing purposes, namely, cell culture reagents including but not limited to liquid and powdered media, frozen cells, cell growth factors, cell cytokines, and cell culture;Performing scientific and medical research for others, namely, evaluating potential therapeutic modalities for treating ophthalmological diseases, disorder and injuries using a stem-cell based research platform; |
| Category: | BIOLOGICAL TISSUE |
| Brand: |
CYTOHEP |
|---|---|
| Description: | Biological tissue, namely, stem cells and tissues derived therefrom for use in treating ophthamlogical diseases, disorders and injuries;Biological tissue, namely, stem cells for scientific research use in the field of ophthamology, and reagents for research and manufacturing purposes, namely, cell culture reagents including but not limited to liquid and powdered media, frozen cells, cell growth factors, cell cytokines, and cell culture;Performing scientific and medical research for others, namely, evaluating potential therapeutic modalities for treating ophthalmological diseases, disorder and injuries using a stem-cell based research platform; |
| Category: | BIOLOGICAL TISSUE |
| Brand: |
CYTORET |
|---|---|
| Description: | Biological tissue, namely, stem cells and tissues derived therefrom for use in treating ophthamlogical diseases, disorders and injuries;Biological tissue, namely, stem cells for scientific research use in the field of ophthamology, and reagents for research and manufacturing purposes, namely, cell culture reagents including but not limited to liquid and powdered media, frozen cells, cell growth factors, cell cytokines, and cell culture;Performing scientific and medical research for others, namely, evaluating potential therapeutic modalities for treating ophthalmological diseases, disorder and injuries using a stem-cell based research platform; |
| Category: | BIOLOGICAL TISSUE |
| Brand: |
CYTOVIS |
|---|---|
| Description: | Biological tissue, namely, stem cells and tissues derived therefrom for use in treating ophthamlogical diseases, disorders and injuries;Biological tissue, namely, stem cells for scientific research use in the field of ophthamology, and reagents for research and manufacturing purposes, namely, cell culture reagents including but not limited to liquid and powdered media, frozen cells, cell growth factors, cell cytokines, and cell culture;Performing scientific and medical research for others, namely, evaluating potential therapeutic modalities for treating ophthalmological diseases, disorder and injuries using a stem-cell based research platform; |
| Category: | BIOLOGICAL TISSUE |
| Brand: |
CYTOVIS |
|---|---|
| Description: | The mark consists of the word CYTOVIS in stylized lettering with CYTO in orange color and VIS in blue color. The letter O in CYTO is a broken circle enclosing a solid blue circle.;Biological tissue, namely, stem cells and tissues derived therefrom for use in treating ophthamlogical diseases, disorders and injuries;The color(s) orange and blue is/are claimed as a feature of the mark.;Biological tissue, namely, stem cells for scientific research use in the field of ophthamology, and reagents for research and manufacturing purposes, namely, cell culture reagents including but not limited to liquid and powdered media, frozen cells, cell growth factors, cell cytokines, and cell culture;Performing scientific and medical research for others, namely, evaluating potential therapeutic modalities for treating ophthalmological diseases, disorder and injuries using a stem-cell based research platform; |
| Category: |